Randomised, double-blind comparison of efficacy and tolerability od diclofenac mouthwash versus placebo in mucositis of oral cavity by radiotherapy

KOSTŘICA, Rom, Jan ROTTENBERG, Jan KVĚCH, Jan BETKA and Pavol JABLONICKÝ. Randomised, double-blind comparison of efficacy and tolerability od diclofenac mouthwash versus placebo in mucositis of oral cavity by radiotherapy. Journal of Clinical Research. Richmond, Surrey, United Kingdom: Brookwood Medical Publications,, 2002, vol. 1, No 5, p. 1-14. ISSN 1369-5207.

Basic information

• Original name: Randomised, double-blind comparison of efficacy and tolerability od diclofenac mouthwash versus placebo in mucositis of oral cavity by radiotherapy
• Authors: KOSTŘICA, Rom (203 Czech Republic, guarantor), Jan ROTTENBERG (203 Czech Republic), Jan KVĚCH (203 Czech Republic), Jan BETKA (203 Czech Republic) and Pavol JABLONICKÝ (203 Czech Republic).
• Edition: Journal of Clinical Research, Richmond, Surrey, United Kingdom, Brookwood Medical Publications, 2002, 1369-5207.

Other information

• Original language: English
• Type of outcome: Article in a journal
• Field of Study: 30200 3.2 Clinical medicine
• Country of publisher: United Kingdom of Great Britain and Northern Ireland
• Confidentiality degree: is not subject to a state or trade secret
• RIV identification code: RIV/00216224:14110/02:00005636
• Organization unit: Faculty of Medicine
• Keywords in English: diclofenac; mouthwash; mucositis; radiotherapy; RTOG/EORTEC; double-blind
• Tags: diclofenac, double-blind, mouthwash, mucositis, radiotherapy, RTOG/EORTEC

Abstract

Diclofenac mouthwash as 15 ml gargle, three times a day, is effective and safe for the treatment of mucositis by radiotherapy, with high acceptability and ease of administration, when compared with placebo.

Links

• MSM 141100003, plan (intention): Name: Zevní prostředí - karcinogeneze - onkologie

Investor: Ministry of Education, Youth and Sports of the CR, Environment - carcinogenesis - oncology